
- Tango Therapeutics (TNGX) has surged 1,229% over the past year.
- Shares are trading at a new all-time high and have strong technical momentum.
- TNGX maintains a 100% “Buy” technical opinion from Barchart.
- Short interest is exceptionally high at 34.16% of the float, underscoring the stock’s highly speculative nature and significant risk.